טוען...
Targeted drug delivery using iRGD peptide for solid cancer treatment
Many solid tumor types, such as pancreatic cancer, have a generally poor prognosis, in part because the delivery of therapeutic regimen is prohibited by pathological abnormalities that block access to tumor vasculature, leading to poor bioavailability. Recent development of tumor penetrating iRGD pe...
שמור ב:
| הוצא לאור ב: | Mol Syst Des Eng |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6258069/ https://ncbi.nlm.nih.gov/pubmed/30498580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1039/C7ME00050B |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|